AZN, IQV Team Up To Accelerate COVID-19 Vaccine Work, RIGL's ITP Drug Repurposed, IMV On Watch

Today's Daily Dose brings you news about Aldeyra's stock sales to two healthcare-focused investment funds, AstraZeneca teaming up with a contract research organization to accelerate the development of its COVID-19 vaccine candidate, Blueprint Medicines' collaboration with Roche, the progress in IMV's COVID-19 vaccine candidate, and the next milestone in Moderna's potential COVID-19 vaccine.

from RTT - Biotech https://ift.tt/32mzZmi
via IFTTT